CD8A and inflammatory bowel disease: As increasing evidence suggests that CD8+ T cells may play an earlier role in IBD development than the CD4+ T cells (160), whether dysregulated NOD2 signaling may affect CD8+ T cell responses by aberrant priming via the cross-presentation pathway remains to be investigated.